Study S000613

A Post-marketing Real-world Study for Evaluating Effectiveness and Safety of Spartina® (Tirzepatide Manufactured by CinnaGen) in Patients With Obesity and Overweight

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07262762
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 175
Start: 2025-11-11
Primary completion: 2026-06-20
Lead sponsor: Cinnagen
Conditions: Obesity & Overweight
Results posted: FALSE

Registered primary outcomes

Proportion of patients with ≥5% weight loss [day 0, 180]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.